Emcure Pharmaceuticals Limited (BOM:544210)

Emcure Pharmaceuticals Statistics

Total Valuation

BOM:544210 has a market cap or net worth of INR 323.29 billion. The enterprise value is 337.29 billion.

Market Cap	323.29B
Enterprise Value	337.29B

Important Dates

The last earnings date was Tuesday, May 5, 2026.

Earnings Date	May 5, 2026
Ex-Dividend Date	Aug 14, 2025

Share Statistics

Current Share Class	189.59M
Shares Outstanding	n/a
Shares Change (YoY)	+1.33%
Shares Change (QoQ)	-0.01%
Owned by Insiders (%)	70.40%
Owned by Institutions (%)	9.26%
Float	41.62M

Valuation Ratios

The trailing PE ratio is 34.97 and the forward PE ratio is 28.36.

PE Ratio	34.97
Forward PE	28.36
PS Ratio	3.51
PB Ratio	6.50
P/TBV Ratio	8.40
P/FCF Ratio	55.45
P/OCF Ratio	34.26
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 18.86, with an EV/FCF ratio of 57.86.

EV / Earnings	36.49
EV / Sales	3.66
EV / EBITDA	18.86
EV / EBIT	24.56
EV / FCF	57.86

Financial Position

The company has a current ratio of 1.43, with a Debt / Equity ratio of 0.31.

Current Ratio	1.43
Quick Ratio	0.71
Debt / Equity	0.31
Debt / EBITDA	0.85
Debt / FCF	2.61
Interest Coverage	9.56

Financial Efficiency

Return on equity (ROE) is 19.57% and return on invested capital (ROIC) is 16.23%.

Return on Equity (ROE)	19.57%
Return on Assets (ROA)	9.62%
Return on Invested Capital (ROIC)	16.23%
Return on Capital Employed (ROCE)	24.10%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	13.67M
Profits Per Employee	1.37M
Employee Count	6,731
Asset Turnover	1.03
Inventory Turnover	1.67

Taxes

In the past 12 months, BOM:544210 has paid 3.46 billion in taxes.

Income Tax	3.46B
Effective Tax Rate	26.87%

Stock Price Statistics

The stock price has increased by +27.05% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+27.05%
50-Day Moving Average	1,631.74
200-Day Moving Average	1,471.73
Relative Strength Index (RSI)	53.28
Average Volume (20 Days)	13,744

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, BOM:544210 had revenue of INR 92.04 billion and earned 9.24 billion in profits. Earnings per share was 48.77.

Revenue	92.04B
Gross Profit	55.46B
Operating Income	13.74B
Pretax Income	12.87B
Net Income	9.24B
EBITDA	17.89B
EBIT	13.74B
Earnings Per Share (EPS)	48.77

Balance Sheet

The company has 1.48 billion in cash and 15.21 billion in debt, with a net cash position of -13.74 billion.

Cash & Cash Equivalents	1.48B
Total Debt	15.21B
Net Cash	-13.74B
Net Cash Per Share	n/a
Equity (Book Value)	49.77B
Book Value Per Share	261.12
Working Capital	17.00B

Cash Flow

In the last 12 months, operating cash flow was 9.44 billion and capital expenditures -3.61 billion, giving a free cash flow of 5.83 billion.

Operating Cash Flow	9.44B
Capital Expenditures	-3.61B
Depreciation & Amortization	4.15B
Net Borrowing	4.88B
Free Cash Flow	5.83B
FCF Per Share	n/a

Margins

Gross margin is 60.26%, with operating and profit margins of 14.92% and 10.04%.

Gross Margin	60.26%
Operating Margin	14.92%
Pretax Margin	13.99%
Profit Margin	10.04%
EBITDA Margin	19.43%
EBIT Margin	14.92%
FCF Margin	6.33%

Dividends & Yields

This stock pays an annual dividend of 3.00, which amounts to a dividend yield of 0.18%.

Dividend Per Share	3.00
Dividend Yield	0.18%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	1
Payout Ratio	6.15%
Buyback Yield	-1.33%
Shareholder Yield	-1.16%
Earnings Yield	2.86%
FCF Yield	1.80%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	6